UBS/CALL/BB BIOTECH N/60.003/0.0333/20.06.25

UBS/CALL/BB BIOTECH N/60.003/0.0333/20.06.25 Stock

Warrant

SBIO4U

CH1312122133

Market Closed - Swiss Exchange 11:15:00 2024-04-15 EDT
0.02 ^CHF	-33.33%

3 months

-33.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BB BIOTECH AG

Chart UBS/CALL/BB BIOTECH N/60.003/0.0333/20.06.25

Latest news about BB BIOTECH AG

BB BIOTECH AG: Disclosure of Shareholdings	05-10	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	05-02	EQ
Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022.	04-27	CI
Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps	04-26	MT

More news

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	BB BIOTECH AG
Issuer	UBS
	SBIO4U
ISIN	CH1312122133
Date issued	2023-12-18
Strike	60 CHF
Maturity	2025-06-20 (400 Days)
Parity	30 : 1
Emission price	0.02 CHF
Emission volume	N/A
Settlement	physique
Currency	CHF

Technical Indicators

Highest since issue	0.05 CHF
Lowest since issue	0.02 CHF
Delta	0.09x
Omega	8.572
Premium	44.8x
Gearing	92.78x
Moneyness	0.6958
Difference Strike	18.25 CHF
Difference Strike %	+30.42%
Spread	0.01 CHF
Spread %	50.00%
Theoretical value	0.0150
Implied Volatility	26.23 %
Total Loss Probability	94.48 %
Intrinsic value	0.000000
Present value	0.0150
Break even	60.45 CHF
Theta	-0x
Vega	0x
Rho	0x

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Companyâs portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Sector

More about the company